Indeed, reinforcing ceruloplasmin activity with agonist drugs could, through the increase in ferroxidase activity, simultaneously decrease the production of reactive oxygen species, limit tissue damage and insure a protection against bacterial infections [26]. The gene discussed is CP; the disease is bacterial infectious disease.